Year |
Citation |
Score |
2017 |
Gabunia K, Herman A, Ray M, Kelemen S, England RN, Cadena RD, Foster WJ, Elliott KJ, Eguchi S, Autieri MV. Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC. Journal of Molecular and Cellular Cardiology. PMID 28257760 DOI: 10.1016/J.Yjmcc.2017.02.005 |
0.766 |
|
2016 |
Kako F, Gabunia K, Ray M, Kelemen SE, England RN, Kako B, Scalia RG, Autieri MV. Interleukin-19 Induces Angiogenesis in the Absence of Hypoxia by Direct and Indirect Immune Mechanisms. American Journal of Physiology. Cell Physiology. ajpcell.00006.2016. PMID 27053520 DOI: 10.1152/Ajpcell.00006.2016 |
0.772 |
|
2014 |
Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, Azuma YT, Munroy MA, Eguchi S, Autieri MV. IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation. The American Journal of Pathology. 184: 2134-43. PMID 24814101 DOI: 10.1016/J.Ajpath.2014.04.001 |
0.731 |
|
2013 |
Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Orr W, Traylor JG, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV. Attenuation of experimental atherosclerosis by interleukin-19. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 2316-24. PMID 23950143 DOI: 10.1161/Atvbaha.113.301521 |
0.72 |
|
2013 |
England RN, Preston KJ, Scalia R, Autieri MV. Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability. American Journal of Physiology. Cell Physiology. 305: C255-65. PMID 23596173 DOI: 10.1152/Ajpcell.00069.2013 |
0.769 |
|
2012 |
England RN, Autieri MV. Anti-inflammatory effects of interleukin-19 in vascular disease. International Journal of Inflammation. 2012: 253583. PMID 22844641 DOI: 10.1155/2012/253583 |
0.657 |
|
2012 |
Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis. 220: 45-52. PMID 21862018 DOI: 10.1016/J.Atherosclerosis.2011.07.095 |
0.668 |
|
2011 |
Gabunia K, Jain S, England RN, Autieri MV. Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. American Journal of Physiology. Cell Physiology. 300: C896-906. PMID 21209363 DOI: 10.1152/Ajpcell.00439.2010 |
0.761 |
|
Show low-probability matches. |